WINSANTOR

WinSanTor Inc. is a private biotechnology company focused on the discovery and development of treatments for peripheral neuropathies. WinSanTor recently completed Phase 1 trials for its lead drug, WST-057, and will begin recruiting for its Phase 2 trials in Canada to treat patients with diabetic peripheral neuropathy... We are impatient. We are exploiting every strategy, mechanism and regulation to accelerate approval of our drugs, including recycling an active ingredient in use for nearly 40 years in Europe and Asia. Currently, we are preparing to start our Phase 3 global study for diabetic peripheral neuropathy. Our goal is to get drug approval in the US as soon as possible, and possibly sooner in other countries. By focusing on patient impact rather than the bottom line, we believe we're creating a new sustainable model for pharma companies based on patient need, not just money... Do you suffer from diabetic neuropathy, chemo-induced neuropathy, or HIV neuropathy? Join our..

Also known as: WinSanTor, Inc.

Primary location: San Diego United States